BUPRENORPHINE
- Product NDC
- 68071-2592
- 11-digit product format
- 680712592
- Labeler code
- 68071
- Product ID
- 68071-2592_d2940ffb-c13c-c66b-e053-2995a90aaba0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- BUPRENORPHINE
- Dosage form
- TABLET
- Route
- SUBLINGUAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA207276
- Marketing category
- ANDA
- Marketing start
- 2017-10-25
- Marketing end
- 0000-00-00
- Substance
- BUPRENORPHINE HYDROCHLORIDE
- Active strength
- 8 mg/1
- Pharmacologic classes
- Partial Opioid Agonists [MoA],Partial Opioid Agonist [EPC]
- DEA schedule
- CIII
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68071-2592-3 | BUPRENORPHINE | 30 in 1 BOTTLE | TABLET | 30 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68071-2592 | BUPRENORPHINE TABLET [NUCARE PHARMACEUTICALS,INC.] | 2 | Legacy NDC, 1 package rows | 20230718_d2940ffb-c13b-c66b-e053-2995a90aaba0.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68071-2592-3 | 68071259203 | 30 TABLET in 1 BOTTLE (68071-2592-3) | 30 tablet | 2021-12-07 | 0000-00-00 | No | No | Current |